BioMatrix Infusion Pharmacy Expands Its Reach with MyLyfe Health Acquisition

In a strategic move aimed at enhancing healthcare delivery, BioMatrix Infusion Pharmacy has officially acquired MyLyfe Health, a company specializing in specialty pharmacy and infusion services. This acquisition marks a significant step for BioMatrix, solidifying its status as a key player in the infusion pharmacy market and expanding its capabilities to assist patients with complex, chronic medical conditions.

Strengthening Service Capabilities

By incorporating MyLyfe Health's expertise and resources, BioMatrix aims to improve patient access to infused medications through both home infusion and ambulatory infusion centers. This expansion not only enhances existing patient support services but also heralds a new era of innovation within pharmaceutical care. The combined strengths of both companies will lead to an improved patient experience and better health outcomes.

Leadership Insights

Ted Kramm, the CEO of BioMatrix, expressed enthusiasm about the acquisition, stating, "We are thrilled to welcome MyLyfe Health to the BioMatrix family. This acquisition aligns with our mission to provide high-quality, patient-centered care while expanding our footprint in the infusion pharmacy sector. Together, we will offer enhanced services, improved medication access, and superior outcomes for our patients." This sentiment reflects the dedication both companies share towards prioritizing the health and well-being of their patients.

Mark Zatyrka, the Founder and CEO of MyLyfe Health, also echoed this excitement. He mentioned, "The combination of our two companies will allow us to further elevate infusion pharmacy services. We are excited about the opportunities ahead and are confident that this partnership will provide greater value to our patients and healthcare providers." Their commitment to patient-first philosophy and exemplary service delivery will soon bear fruit through this merger.

A Seamless Integration

As both organizations integrate, they are committed to maintaining a seamless transition for patients, providers, and partners alike. The aim is to bolster a shared mission of excellence in delivering patient-centric care. MyLyfe’s consistent focus on the quality of life for patients, bolstered by its clinical expertise, will contribute significantly to this cooperative endeavor. Ensuring the safe administration of infused medications and providing compassionate care remain at the core of both companies' mission.

Commitment to Innovation

BioMatrix has a clear mission to expand its specialty infusion pharmacy services, and this acquisition underscores that commitment. The partnership will not only enhance capabilities but also serve as a platform for continued innovation in the field of pharmaceutical care. The integration is expected to foster an environment that is conducive to growth and enhanced service delivery, benefiting healthcare providers and patients alike.

With this acquisition, both BioMatrix and MyLyfe Health are on the brink of reshaping the landscape of infusion services, ensuring that patients with chronic conditions receive the highest standard of care they deserve.

For more information on BioMatrix Infusion Pharmacy and MyLyfe Health’s offerings, visit BioMatrix and MyLyfe Health.